6-羟多巴诱致帕金森病大鼠模型中orexin系统的进行性变化(英文)

Progressive changes of orexin system in a rat model of 6-hydroxydopamine-induced Parkinson’s disease

目的帕金森病(Parkinson’s disease,PD)患者经常发生以白天睡眠过多和睡眠猝发为特征的睡眠障碍,其发病机理可能与下丘脑orexin神经元的丢失及其引发的脑脊液中orexin含量降低有关。本文旨在探讨PD进程中orexin系统的动态变化。方法大鼠内侧前脑束中注入6-羟多巴建立PD模型,运用免疫组织化学法对orexin-A阳性和酪氨酸羟化酶(tyrosine hydroxylase,TH)阳性神经元进行染色而后计数,用ELISA法对脑脊液中orexin-A的含量进行检测。结果 6-羟多巴能导致中脑TH神经元的快速凋亡,而orexin-A神经元对此变化不敏感。此外,orexin-A神经元数量在术后21天时开始下降,至第49天时下降幅度达到30%左右。与对照组相比,脑脊液中的orexin-A水平并不随PD进程发生明显改变,并且orexin-A阳性纤维在一些睡眠调节相关脑区(如结节乳头体核)内也无明显的数量变化。结论以上结果揭示了orexin系统随PD进程的动态变化情况,对于以逆转orexin神经元丢失和缓解PD病人睡眠障碍为目的的药物研发具有一定的指导意义。

Objective Sleep disturbance,which is characterized by excessive daytime sleepiness and sleep attacks,is frequently observed in patients with Parkinson’s disease（PD）.Loss of orexin neurons in hypothalamus and the resultant decreased level of orexin in cerebrospinal fluid（CSF）found in narcolepsy patients may also play an essential role in the pathogenesis of sleep disturbance.The present study aimed to investigate the possible changes in the orexin system during PD progression.Methods After the establishment of a rat PD model by injecting 6-hydroxydopamine（6-OHDA）into the medial forebrain bundle,the numbers of orexin-A-and tyrosine hydroxylase（TH）-positive neurons,and the levels of orexin-A fibers and orexin-A in CSF were examined by immunohistochemistry and ELISA assay,respectively.Results Compared to the TH-containing neurons that exhibited fast degeneration in response to 6-OHDA,orexin-A-containing neurons were less sensitive to 6-OHDA.The number of orexin-A-positive neurons began to decrease at day 21 after operation,and at day 49,it decreased by 30%of the initial level.The orexin-A level in CSF of PD rats did not show any obvious fluctuations compared to the control,and there was no obvious reduction in the density of orexin-A-positive fibers in brain areas such as tuberomammillary nucleus.Conclusion These results reveal for the first time the dynamic changes of orexin system during the progression of PD.This may provide valuable information for drug development to reverse the loss of orexin neurons and sleep disturbance in PD patients.